{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T11:24:43Z","timestamp":1751541883516,"version":"3.40.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"1-3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ejphar.2013.03.007","type":"journal-article","created":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T13:33:30Z","timestamp":1363872810000},"page":"424-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure"],"prefix":"10.1016","volume":"715","author":[{"given":"Alison","family":"Oliveto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Mancino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nichole","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Cargile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Benjamin Guise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren","family":"Bickel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Brooks Gentry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.03.007_bib1","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1523\/JNEUROSCI.11-12-03830.1991","article-title":"Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input","volume":"11","author":"Akaoka","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2013.03.007_bib2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.2042-7158.1990.tb06575.x","article-title":"Effect of clonidine, nimodipine and diltiazem on the in vitro opioid withdrawal response in the guinea-pig ileum","volume":"42","author":"Alfaro","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib3","first-page":"CD003409","article-title":"Methadone at tapered doses for the management of opioid withdrawal","author":"Amato","year":"2005","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.ejphar.2013.03.007_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(87)90176-2","article-title":"Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats","volume":"137","author":"Baeyens","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF02246042","article-title":"Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine","volume":"104","author":"Barrios","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2013.03.007_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s002109900179","article-title":"Short-acting NMDA receptor antagonist MRZ 2\/576 produces prolonged suppression of morphine withdrawal in mice","volume":"361","author":"Belozertseva","year":"2000","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0022-3565(25)10277-2","article-title":"A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans","volume":"264","author":"Bickel","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.03.007_bib8","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0028-3908(99)00232-4","article-title":"Verapamil prevents withdrawal excitation of oxytocin neurones in morphine-dependent rats","volume":"39","author":"Blackburn-Munro","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2013.03.007_bib9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1476-5381.1986.tb10236.x","article-title":"Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats","volume":"88","author":"Bongianni","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1067\/mcp.2001.112513","article-title":"Pharmacokinetic interaction between single oral doses of diltiazem and sirolimus in healthy volunteers","volume":"69","author":"Bottiger","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2013.03.007_bib11","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM198212233072605","article-title":"Mechanism of action calcium channel-blocking agents","volume":"307","author":"Braunwald","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2013.03.007_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0028-3908(97)00006-3","article-title":"Competitive and glycine\/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats","volume":"36","author":"Bristow","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2013.03.007_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0306-3623(93)90008-L","article-title":"Effect of nimodipine, diltiazem and Bay K 8644 on the behavioural and neurochemical changes associated with naloxone-precipitated withdrawal in the rat. A comparison with clonidine","volume":"24","author":"Colado","year":"1993","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1526-4637.2003.03038.x","article-title":"A survey of chronic noncancer pain patients prescribed opioid analgesics","volume":"4","author":"Cowan","year":"2003","journal-title":"Pain Med."},{"key":"10.1016\/j.ejphar.2013.03.007_bib15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0002-9149(92)90196-6","article-title":"Acute conversion of paroxysmal supraventrical tachycardia with intravenous diltiazem IV Diltiazem Study Group","volume":"70","author":"Dougherty","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib16","article-title":"Buprenorphine for the management of opioid withdrawal","author":"Gowing","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejphar.2013.03.007_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1360-0443.2002.00037.x","article-title":"Alpha2-adrenergic agonists in opioid withdrawal","volume":"97","author":"Gowing","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.ejphar.2013.03.007_bib18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1517\/14656566.2.5.731","article-title":"The current status of antihypertensive treatments: into the new millennium","volume":"2","author":"Hardman","year":"2001","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2013.03.007_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/bja\/aeg118","article-title":"Effects of three different L-type Ca 2+ entry blockers in airway constriction induced by muscarinic receptor stimulation","volume":"90","author":"Hirota","year":"2003","journal-title":"Br. J. Anesth."},{"key":"10.1016\/j.ejphar.2013.03.007_bib20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2125.1987.tb03226.x","article-title":"Pharmacokinetics and pharmacodynamics of two formulations of verapamil","volume":"24","author":"Hla","year":"1987","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib21","series-title":"Drug Addiction I","first-page":"197","article-title":"Assessment of the abuse potential of morphine-like drugs (methods used in man)","author":"Jasinski","year":"1977"},{"key":"10.1016\/j.ejphar.2013.03.007_bib22","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/archpsyc.1985.01790340041006","article-title":"Clonidine in morphine withdrawal. Differential effects on signs and symptoms","volume":"42","author":"Jasinski","year":"1985","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2013.03.007_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/01.HYP.26.1.143","article-title":"Divergent effects of dihydropyridine and phenyalakamine calcium channel antagonist classes on automatic function in human hypertension","volume":"26","author":"Kailasam","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2013.03.007_bib500","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF02244940","article-title":"Drug discrimination by humans compared to nonhumans: current status and future directions","volume":"111","author":"Kamien","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2013.03.007_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00008877-199406000-00009","article-title":"Triazolam discrimination by humans under a novel response procedure: effects of buspirone and lorazepam","volume":"5","author":"Kamien","year":"1994","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib501","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1534582303262095","article-title":"Clinical neuropharmacology of drugs of abuse: a comparison of drug-discrimination and subject-report measures","volume":"2","author":"Kelly","year":"2003","journal-title":"Behavioral and Cognitive Neuroscience Reviews"},{"key":"10.1016\/j.ejphar.2013.03.007_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-2999(96)00651-6","article-title":"Diltiazem inhibits naloxone-precipitated and spontaneous morphine withdrawal in rats","volume":"316","author":"Kishioka","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.31887\/DCNS.2007.9.2\/hkleber","article-title":"Pharmacologic treatments for opioid dependence: detoxification and maintenance options","volume":"9","author":"Kleber","year":"2007","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2013.03.007_bib27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.31887\/DCNS.2007.9.2\/hkleber","article-title":"Pharmacologic treatments for opioid dependence: detoxification and maintenance options","volume":"9","author":"Kleber","year":"2007","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2013.03.007_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-4899-1648-8_11","article-title":"Neuropharmacology of cocaine and ethanol dependence","volume":"10","author":"Koob","year":"1992","journal-title":"Recent Dev. Alcohol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0893-133X(95)00065-L","article-title":"The severity of naloxone-precipitated opiate withdrawal is attenuated by felbamate, a possible glycine antagonist","volume":"13","author":"Kosten","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2013.03.007_bib30","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0091-3057(90)90366-P","article-title":"Suppression by ketamine and dextromethorphan of precipitated abstinence syndrome in rats","volume":"35","author":"Koyuncuoglu","year":"1990","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2013.03.007_bib31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/mol.51.2.262","article-title":"1, 5-Benzothiazepine binding domains is located on the extracellular side of the cardiac L-type ca2 channel","volume":"51","author":"Kurokawa","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cpt1971122part1245","article-title":"Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man","volume":"12","author":"Martin","year":"1971","journal-title":"Clin. Pharmacol. Ther."},{"year":"1981","series-title":"Profile of Mood States","author":"McNair","key":"10.1016\/j.ejphar.2013.03.007_bib33"},{"key":"10.1016\/j.ejphar.2013.03.007_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/1043-6618(90)90787-E","article-title":"Clonidine and nifedipine inhibit the abstinence but not the development of dependence in isolated guinea pig ileum","volume":"22","author":"Morrone","year":"1990","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2013.03.007_bib35","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1523\/JNEUROSCI.12-07-02439.1992","article-title":"Molecular mechanisms of drug addiction","volume":"12","author":"Nestler","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2013.03.007_bib36","first-page":"190","article-title":"Nifedipine activates sympathetic nervous system: addictive effects of cold pressor test (abstract)","volume":"15","author":"Noll","year":"1994","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2013.03.007_bib37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1037\/1064-1297.11.3.237","article-title":"D-cycloserine-Naloxone interactions in opioid-dependent humans under a novel-response naloxone discrimination procedure","volume":"11","author":"Oliveto","year":"2003","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejphar.2004.03.024","article-title":"Isradipine and dextromethorphan in methadone-maintained humans under a naloxone discrimination procedure","volume":"491","author":"Oliveto","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00008877-200303000-00001","article-title":"Clonidine and yohimbine in opioid-dependent humans responding under a naloxone novel-response discrimination procedure","volume":"14","author":"Oliveto","year":"2003","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0091-3057(01)00637-2","article-title":"Butorphanol and nalbuphine in opioid-dependent humans under a naloxone discrimination procedure","volume":"71","author":"Oliveto","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2013.03.007_bib41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF02249331","article-title":"Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure","volume":"114","author":"Oliveto","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2013.03.007_bib42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1037\/1064-1297.6.2.169","article-title":"Naloxone discrimination in opioid-dependent humans under a novel-response discrimination procedure","volume":"6","author":"Oliveto","year":"1998","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1037\/1064-1297.6.2.169","article-title":"Hydromorphone-naloxone combinations in opioid-dependent humans under a naloxone novel-response discrimination procedure","volume":"6","author":"Oliveto","year":"1998","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib44","first-page":"177","article-title":"Calcium channel antagonists. Part IV: side effects and contraindications drug interactions and combinations","volume":"2","author":"Opie","year":"1988"},{"key":"10.1016\/j.ejphar.2013.03.007_bib45","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0028-3908(98)00105-1","article-title":"Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists","volume":"37","author":"Popik","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2013.03.007_bib46","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0022-3565(25)39261-X","article-title":"Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline","volume":"243","author":"Preston","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.03.007_bib47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(88)90488-8","article-title":"Prolonged morphine treatment increases rat brain dihydropyridine binding sites: possible involvement in development of morphine dependence","volume":"146","author":"Ramkumar","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib48","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0006-8993(89)91466-2","article-title":"Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis","volume":"505","author":"Rasmussen","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2013.03.007_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(91)90358-W","article-title":"NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal","volume":"197","author":"Rasmussen","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.ne.07.030184.002303","article-title":"Multiple mechanisms of withdrawal from opioid drugs","volume":"7","author":"Redmond","year":"1984","journal-title":"Ann. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2013.03.007_bib51","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2165\/00003088-199834060-00003","article-title":"Clinical Pharmacokinetics of Vasodilators","volume":"34","author":"Roland","year":"1998","journal-title":"Clin. Pharmacokinetics"},{"key":"10.1016\/j.ejphar.2013.03.007_bib52","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/00004872-199715110-00019","article-title":"Clinical results of the verapamil in hypertension and atherosclerosis study","volume":"15","author":"Rosei","year":"1997","journal-title":"J. Hypertension"},{"key":"10.1016\/j.ejphar.2013.03.007_bib53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00005053-198502000-00007","article-title":"Success and failure at outpatient opioid detoxification. Evaluating the process of clonidine- and methadone-assisted withdrawal","volume":"173","author":"Rounsaville","year":"1985","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.ejphar.2013.03.007_bib54","unstructured":"Sanders, N.C., Mancino, M.J., Gentry, W.B., Bickel, W.K., Guise, J.B., Oliveto, A.H., 2012. Effects of gabapentin in opioid-dependent individuals during a 10-day buprenorphine detoxification. In: The 2012 Annual Meeting of the College on Problems of Drug Dependence. Palm Springs, CA."},{"key":"10.1016\/j.ejphar.2013.03.007_bib55","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/clpt.1993.148","article-title":"The effects of age and gender on the stereoselective pharmacokinetics of verapamil","volume":"54","author":"Sasaki","year":"1993","journal-title":"Clin Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2013.03.007_bib502","doi-asserted-by":"crossref","unstructured":"Schuster, C.R., Johanson, C.E., 1988. Relationship between the discriminative stimulus properties and subjective effects of drugs. In: Transduction Mechanisms of Drug Stimuli, Colpaert, F.C. Balster, R.L. (Eds.), Springer-Verlag, Berlin, pp. 161\u2013175","DOI":"10.1007\/978-3-642-73223-2_13"},{"key":"10.1016\/j.ejphar.2013.03.007_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2147\/JEP.S15240","article-title":"Role of calcium in morphine dependence and naloxone-precipitated withdrawal in mice","volume":"3","author":"Seth","year":"2011","journal-title":"J. Exp. Pharmacol."},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2013.03.007_bib57","first-page":"S19","article-title":"Calcium channel blocking drugs in the management of drug dependence, withdrawal and craving. A clinical pilot study with nifedipine and verapamil","volume":"27","author":"Shulman","year":"1998","journal-title":"Aust. Family Physician"},{"key":"10.1016\/j.ejphar.2013.03.007_bib58","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14656560903037168","article-title":"Opioid dependence treatment: options in pharmacotherapy","volume":"10","author":"Stotts","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2013.03.007_bib59","doi-asserted-by":"crossref","first-page":"9108","DOI":"10.1073\/pnas.87.23.9108","article-title":"Identification of a phenylalkylamine binding region within the alpha1 subunit of skeletal muscle Ca2 channels","volume":"87","author":"Striessnig","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2013.03.007_bib60","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1073\/pnas.88.23.10769","article-title":"Dihydropyridine receptor of l-type Ca2 channels: identification of binding domains for [3H] (+)-PN200-110 and [3H]azidopine within the alpha1 subunit","volume":"88","author":"Striessnig","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2013.03.007_bib61","article-title":"Results from the 2009 National Survey on Drug Use and Health","volume":"vol. I","author":"Substance Abuse and Mental Health Services Administration","year":"2010"},{"key":"10.1016\/j.ejphar.2013.03.007_bib62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/00365529309096060","article-title":"Dihydropyridine calcium channel antagonists disrupt migrating myoelectric complexes and counteract intestinal disorders associated with morphine withdrawal diarrhea","volume":"28","author":"Thollander","year":"1993","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib63","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0006-8993(96)00187-4","article-title":"Inhibitory effects of diltiazem, an L-type Ca2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioid-dependent rats","volume":"722","author":"Tokuyama","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2013.03.007_bib64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0014-2999(95)00645-1","article-title":"Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome","volume":"295","author":"Tokuyama","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.007_bib65","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1067\/mhj.2001.119127","article-title":"Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease","volume":"142","author":"White","year":"2001","journal-title":"Am. Heart J."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913001970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913001970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T01:23:08Z","timestamp":1745976188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913001970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":68,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0014299913001970"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.03.007","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}